The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock
AC West, BP Martin, DA Andrews, SJ Hogg, A Banerjee, G Grigoriadis, RW Johnstone, J Shortt
ONCOGENESIS | NATURE PUBLISHING GROUP | Published : 2016
ACW was supported by the Cancer Council of Victoria (CCV). SJH is funded by the Leukaemia Foundation of Australia (LFA). JS is supported by funding from the CCV, LFA, Eva & Les Erdi/Snowdome Foundation and Victorian Cancer Agency (VCA). RWJ is a Senior Principal Research Fellow of the National Health & Medical Research Council of Australia (NHMRC) and is supported by NHMRC Program and Project Grants, the CCV and VCA. GG is a VCA Clinical Research Fellow. DAA is supported by an NHMRC Career Development Fellowship.